The global in-vitro toxicity testing market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). In vitro is the process that helps examine harmful chemicals over the isolated part of the organism. It is used to identify hazardous chemical substances and helps detect the toxicity at the early stages of the development of new products such as drugs, cosmetics, and food additives. The in vitro toxicity testing is mainly used for safety evaluation in drug development and also for ranking the chemicals according to their potency. The absorption, distribution, metabolism, excretion (ADME), dose-response, threshold response of the drug can also be determined by the in vitro toxicity testing.

The major factors that are expected to accelerate the market growth during the forecast period include an increase in awareness about the environmental concerns and an increase in the number of R&D procedures, which require in vitro testing, ban on animal testing. Moreover, advancements in genetics and genetic screening approaches and the emergence of new approaches of 3D cell culture are also anticipated to boost the global in-vitro toxicity testing market during the forecast period.

The global in-vitro toxicity testing market analysis includes some of the key market players such as Agilent Technologies, Inc., BioReliance, Inc., Alere, Inc., Charles River Laboratories International, Inc., and General Electric Company, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, In August 2019, Covance launched a laboratory solution within its functional service provider (FSPx) offering, comprising a clinical analytics service and clinical operations capabilities.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape:  Agilent Technologies, Inc., BioReliance, Inc., Alere, Inc., Charles River Laboratories International, Inc., and General Electric Company, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global In-Vitro Toxicity Testing Market by Segment

By Product & Service 

• Consumables

• Assay

• Equipment

• Software

• Services

By Toxicity Endpoints 

• ADME

• Skin Irritation

• Corrosion

• Other

By Industry 

• Pharmaceutical

• Cosmetics

• Food

• Others

Global In-Vitro Toxicity Testing Market by Region